SLT v. Sharplan
This article was originally published in The Gray Sheet
Executive Summary
Surgical Laser Technologies, Inc. wins patent infringement suit against Laser Industries, Inc. subsidiary Sharplan. In a trial in the U.S. District Court for the Eastern District of Pennsylvania, a jury found that the majority of Sharplan's sapphire contact probes and scalpels, which are no longer sold in the U.S., infringe a family of SLT patents for its Contact Laser. In addition, the jury found that Sharplan's conical sculpted fibers, which are still sold in the U.S., infringe one of the Contact Laser patents. The jury also upheld the validity of the three SLT patents "that form the core of SLT's Contact Laser technology," SLT says, and concluded that SLT does not infringe a laser patent licensed by Sharplan from the University of Washington ("The Gray Sheet" May 6, 1991, I&W-7). Sharplan plans to introduce a substitute for the conical fibers, which constituted less that 1% of 1992 sales, and says that it will appeal the decision. Damages will be addressed in a subsequent proceeding.
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.